Wei Liang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Liang has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
Pei Jiang
Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2 shared publicationsBaolin Liu
Institute of Biothermal and Technology, University of Shanghai for Science and Technology, Shanghai, China
1 shared publication- Baolin Liu
University of Shanghai for Science and Technology
1 shared publication Hongyun Shan
Ministry of Education-Shanghai Key Laboratory of Children's Environmental Health, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication- Mu Chen
Univ Shanghai Sci & Technol, Inst Biothermal Sci & Technol, Shanghai, Peoples R China
1 shared publication Qin Li
Department of Obstetrics and Gynecology, Shanghai Changhai Hospital, Shanghai, China
1 shared publication
Latest Publications
- 18 October 2023
- Published by Elsevier in Cryobiology
- Vol. 113, 104786
Effect of cryoprotectant-induced intracellular ice formation and crystallinity on bacteria during cryopreservation
- 18 October 2023
- Published by Elsevier in Cryobiology
- Vol. 113, 104786
Effect of cryoprotectant-induced intracellular ice formation and crystallinity on bacteria during cryopreservation
- 1 April 2022
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 20 (2) , 138-148
Cryopreservation of Infant Gut Microbiota with Natural Cryoprotectants
A growing body of evidence has demonstrated the importance of the gut microbiome in human health. In general, fecal microbial samples are used to study the mechanisms of relevant diseases. In this context, it is worth mentioning that an optimized cryopreservation method is urgently needed to successfully perform clinical diagnosis, therapy, and scientific investigations of the gut microbiome without affecting its viability and biological activity. In this study, we aimed to test the relative cryopreservation efficiency of different nontoxic natural cryoprotectants using infant fecal and meconium samples. First, we selected two facultative and two obligate anaerobic bacteria as the experimental gut microbial strain to compare these cryoprotectants' toxicity and concentration-dependent bacteria viabilities after cryopreservation, then the viabilities and bacterial diversity of mixed facultative and obligate anaerobic bacteria. Finally, we explored the effects of optimized cryoprotectants for meconium and infant feces after cryopreservation using 16S rRNA sequencing analyses. In addition, to better understand the effectiveness of these cryoprotectants, we used different freeze–thaw conditions mimicking real-life situations in the process of distribution. We found that the better choice for the infant fecal sample's cryopreservation was 100 mg/mL trehalose, whereas 200 mg/mL trehalose/betaine was the optimum choice for meconium cryopreservation. We hope that our results will shed light on the importance of natural cryoprotectants toward the long-term and stable viability of invaluable human gut microbial specimens.
- 1 April 2022
- Published by SAGE Publications in Biopreservation and Biobanking
- Vol. 20 (2) , 138-148
Cryopreservation of Infant Gut Microbiota with Natural Cryoprotectants
A growing body of evidence has demonstrated the importance of the gut microbiome in human health. In general, fecal microbial samples are used to study the mechanisms of relevant diseases. In this context, it is worth mentioning that an optimized cryopreservation method is urgently needed to successfully perform clinical diagnosis, therapy, and scientific investigations of the gut microbiome without affecting its viability and biological activity. In this study, we aimed to test the relative cryopreservation efficiency of different nontoxic natural cryoprotectants using infant fecal and meconium samples. First, we selected two facultative and two obligate anaerobic bacteria as the experimental gut microbial strain to compare these cryoprotectants' toxicity and concentration-dependent bacteria viabilities after cryopreservation, then the viabilities and bacterial diversity of mixed facultative and obligate anaerobic bacteria. Finally, we explored the effects of optimized cryoprotectants for meconium and infant feces after cryopreservation using 16S rRNA sequencing analyses. In addition, to better understand the effectiveness of these cryoprotectants, we used different freeze–thaw conditions mimicking real-life situations in the process of distribution. We found that the better choice for the infant fecal sample's cryopreservation was 100 mg/mL trehalose, whereas 200 mg/mL trehalose/betaine was the optimum choice for meconium cryopreservation. We hope that our results will shed light on the importance of natural cryoprotectants toward the long-term and stable viability of invaluable human gut microbial specimens.